Center for Pharmaceutical Policy and Prescribing Publications

2017

  • Stroupe KT, Smith BM, Bailey L, Adas J, Gellad WF, Suda K, Huo Z, Tully S, Burk M, Cunningham F. Medication Acquisition by Veterans Dually Eligible for Veterans Affairs and Medicare Part D Pharmacy Benefits. Am J Health Syst Pharm. 2017 Feb; 74(3): 140-150.
  • Thorpe JM, Thorpe CT, Gellad WF, Good CB, Hanlon JT, Mor MK, Pleis JR, Schleiden LJ, Van Houtven CH. Dual Health Care System Use and High-Risk Prescribing in Patients With Dementia: A National Cohort Study. Ann Intern Med. 2017 Feb; 166(3): 157-163.

2016

  • Gellad WF, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Mor M, Hale JA, Radomski T, Hausmann LR, Fine MJ, Good CB. Overlapping Buprenorphine, Opioid, and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Department of Veterans of Medicare Part D. Subst Abuse. 2016 Dec. epub ahead of print doi: 10.1080/08897077.2016.1267071.
  • Cochran G, Gordon AJ, Lo-Ciganic WH, Gellad WF, Frazier W, Lobo C, Chang CH, Zheng P, Donohue JM. An Examination of Claims-Based Predictors of Overdose from a Large Medicaid Program. Med Care. 2016 Dec. Epub ahead of print. DOI: 10.1097/MLR.0000000000000676
  • Kabiri M, Chhatwal J, Donohue JM, Roberts MS, James AE, Dunn MA, Gellad MF. Long-term Disease and Economic Outcomes of Prior Authorization Criteria for Hepatitis C Treatment in Pennsylvania Medicaid. Healthcare. 2016. epub ahead of print. DOI: 10.1016/j.hjdsi.2016.11.001.
  • Marcum ZA, Gellad WF. Improving Medication Adherence: Keep Your Eyes on the Prize. J Gen Intern Med. 2016 Nov. epub ahead of print. DOI: 10.1007/s11606-016-3927-4.
  • Naples JG, Gellad WF, Hanlon JT. The Role of Opioid Analgesics in Geriatric Pain Management. Clin Geriatr Med. 2016 Nov;32(4):725-735.
  • Roberts AW, Gellad WF, Skinner AC. Lock-In Programs and the Opioid Epidemic: A Call for Evidence. Am J Public Health. 2016 Nov;106(11):1918-1919.
  • Rottman BM, Marcum ZA, Thorpe CT, Gellad WF. Medication Adherence as a Learning Process: Insights from Cognitive Psychology. Health Psychol Rev. 2016 Oct 5:1-37.
  • Thorpe CT, Fowler NR, Harrigan K, Zhao X, Kang Y, Hanlon JT, Gellad WF, Schleiden LJ, Thorpe JM. Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries. J Am Geriatr Soc. 2016 Sep;64(9):1806-14.
  • Gellad WF, Good CB. Prescription of Brand-Name Medications When Generic Alternatives Are Available-Patently Unfair. JAMA Intern Med. 2016 Sep 1;176(9):1323-4.
  • Lo-Ciganic WH, Donohue JM, Jones BL, Perera S, Thorpe JM, Thorpe CT, Marcum ZA, Gellad WF. Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program. J Gen Intern Med. 2016 Sep;31(9):1052-60.
  • Lo-Ciganic WH, Gellad WF, Huskamp HA, Choudhry NK, Chang CC, Zhang R, Jones BL, Guclu H, Richards-Shubik S, Donohue JM. Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models. Med Care. 2016 Jul;54(7):725-32.
  • Cochran GT, Engel RJ, Hruschak VJ, Tarter RE. Prescription Opioid Misuse Among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research. J Pharm Pract. 2016 Jul 8. [Epub ahead of print].
  • Marcum ZA, Perera S, Thorpe JM, Switzer GE, Castle NG, Strotmeyer ES, Simonsick EM, Ayonayon HN, Phillips CL, Rubin S, Zucker-Levin AR, Bauer DC, Shorr RI, Kang Y, Gray SL, Hanlon JT; Health ABC Study. Antidepressant Use and Recurrent Falls in Community-Dwelling Older Adults: Findings From the Health ABC Study. Ann Pharmacother. 2016 Jul;50(7):525-33.
  • Marcum ZA, Bellon JE, Li J, Gellad WF, Donohue JM. New chronic disease medication prescribing by nurse practitioners, physician assistants, and primary care physicians: a cohort study. BMC Health Serv Res. 2016 Jul 27;16:312.
  • Donohue JM, Normand SL, Horvitz-Lennon M, Men A, Berndt ER, Huskamp HA. Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures. J Ment Health Policy Econ. 2016 Jun;19(2):69-78.
  • Gordon A, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Donohue JM. Treatment Quality for Buprenorphine Care: The Pot at the End of the Rainbow. J Addict Med. 2016 May-Jun;10(3):210-1.
  • Cochran G, Bacci JL, Ylioja T, Hruschak V, Miller S, Seybert AL, Tarter R. Prescription opioid use: Patient characteristics and misuse in community pharmacy. J Am Pharm Assoc (2003). 2016 May-Jun;56(3):248-256.e6.
  • Radomski TR, Zhao X, Thorpe CT, Thorpe JM, Good CB, Mor MK, Fine MJ, Gellad WF. VA and Medicare Utilization Among Dually Enrolled Veterans with Type 2 Diabetes: A Latent Class Analysis. J Gen Intern Med. 2016 May;31(5):524-31.
  • Baksh SN, Gellad WF, Alexander GC. Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients. Drug Saf. 2016 May;39(5):375-80.
  • Lo-Ciganic WH, Gellad WF, Gordon AJ, Cochran G, Zemaitis MA, Cathers T, Kelley D, Donohue JM. Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization. Addiction. 2016 May;111(5):892-902.
  • Stroupe KT, Bailey L, Gellad WF, Suda K, Huo Z, Martinez R, Burk M, Cunningham F, Smith BM. Veterans' Pharmacy and Health Care Utilization Following Implementation of the Medicare Part D Pharmacy Benefit. Med Care Res Rev. 2016 Apr 17. pii: 1077558716643887.
  • Cochran G, Gordon AJ, Field C, Bacci J, Dhital R, Ylioja T, Stitzer M, Kelly T, Tarter R. Developing a framework of care for opioid medication misuse in community pharmacy. Res Social Adm Pharm. 2016 Mar-Apr;12(2):293-301.
  • Tang Y, Chang CC, Lave JR, Gellad WF, Huskamp HA, Donohue JM. Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior. J Ment Health Policy Econ. 2016 Mar;19(1):45-59.
  • Gellad WF. The Veterans Choice Act and Dual Health System Use. J Gen Intern Med. 2016 Feb;31(2):153-4.
  • Radomski TR, Good CB, Thorpe CT, Zhao X, Marcum ZA, Glassman PA, Lowe J, Mor MK, Fine MJ, Gellad WF. Variation in Formulary Management Practices Within the Department of Veterans Affairs Health Care System. J Manag Care Spec Pharm. 2016 Feb;22(2):114-20.
  • Lee JS, Giesler DL, Gellad WF, Fine MJ. Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia: A Systematic Review. JAMA. 2016 Feb 9;315(6):593-602.
  • Good CB, Gellad WF. Off-label Drug Use and Adverse Drug Events: Turning up the Heat on Off-label Prescribing. JAMA Intern Med. 2016 Jan;176(1):63-4.

2015

  • Marcum ZA, Perera S, Newman AB, Thorpe JM, Switzer GE, Gray SL, Simonsick EM, Shorr RI, Bauer DC, Castle NG, Studenski SA, Hanlon JT; Health ABC Study. Antihypertensive Use and Recurrent Falls in Community-Dwelling Older Adults: Findings From the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1562-8. 
  • Marcum ZA, Perera S, Thorpe JM, Switzer GE, Gray SL, Castle NG, Strotmeyer ES, Simonsick EM, Bauer DC, Shorr RI, Studenski SA, Hanlon JT; Health ABC Study, USA. Anticholinergic Use and Recurrent Falls in Community-Dwelling Older Adults: Findings From the Health ABC Study. Ann Pharmacother. 2015 Nov;49(11):1214-21.
  • Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM. Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program. J Addict Med. 2015 Nov-Dec;9(6):470-7.
  • Rocco P, Gellad WF, Donohue JM. Modernizing Medicaid Managed Care: Can States Meet the Data Challenges? JAMA. 2015 Oct 20;314(15):1559-60.
  • Anderson TS, Good CB, Gellad WF. Prevalence and compensation of academic leaders, professors, and trustees on publicly traded US healthcare company boards of directors: cross sectional study. BMJ. 2015 Sep 29;351:h4826.
  • Lund BC, Carrel M, Gellad WF, Chrischilles EA, Kaboli PJ. Incidence- Versus Prevalence-Based Measures of Inappropriate Prescribing in the Veterans Health Administration. J Am Geriatr Soc. 2015 Aug;63(8):1601-7.
  • Gellad WF, Flynn KE, Alexander GC. Evaluation of Flibanserin: Science and Advocacy at the FDA. JAMA. 2015 Sep 1;314(9):869-70.
  • Cochran G, Field C, Lawson K. Pharmacists Who Screen and Discuss Opioid Misuse With Patients: Future Directions for Research and Practice. J Pharm Pract. 2015 Aug;28(4):404-12.
  • Lo-Ciganic WH, Donohue JM, Thorpe JM, Perera S, Thorpe CT, Marcum ZA, Gellad WF. Using machine learning to examine medication adherence thresholds and risk of hospitalization. Med Care. 2015 Aug;53(8):720-8.  
  • Donohue JM, Papademetriou E, Henderson RR, Frazee SG, Eibner C, Mulcahy AW, Mehrotra A, Bharill S, Cui C, Stein BD, Gellad WF. Early Marketplace Enrollees Were Older And Used More Medication Than Later Enrollees; Marketplaces Pooled Risk. Health Aff (Millwood). 2015 Jun;34(6):1049-56.
  • Thorpe CT, Johnson H, Dopp AL, Thorpe JM, Ronk K, Everett CM, Palta M, Mott DA, Chewning B, Schleiden L, Smith MA. Medication oversupply in patients with diabetes. Res Social Adm Pharm. 2015 May-Jun;11(3):382-400. 
  • Anderson TS, Huskamp HA, Epstein AJ, Barry CL, Men A, Berndt ER, Horvitz-Lennon M, Normand SL, Donohue JM. Antipsychotic prescribing: do conflict of interest policies make a difference? Med Care. 2015 Apr;53(4):338-45.  
  • Thorpe CT, Gellad WF, Good CB, Zhang S, Zhao X, Mor M, Fine MJ. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care. 2015 Apr;38(4):588-95. 
  • Marcum ZA, Driessen J, Thorpe CT, Donohue JM, Gellad WF. Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics. Ann Pharmacother. 2015 Mar;49(3):285-92.
  • Prentice JC, Conlin PR, Gellad WF, Edelman D, Lee TA, Pizer SD. Long-term outcomes of analogue insulin compared with NPH for patients with type 2 diabetes mellitus. Am J Manag Care. 2015 Mar 1;21(3):e235-43.
  • Bao Y, Tang Y, Donohue J. Retaining Part D's comprehensive coverage of antidepressants: not a silver bullet. JAMA Psychiatry. 2015 Mar;72(3):201-2.
  • Cochran G, Woo B, Lo-Ciganic WH, Gordon AJ, Donohue JM, Gellad WF. Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review. Subst Abus. 2015;36(2):192-202.
  • Gellad WF, Zhao X, Thorpe CT, Mor MK, Good CB, Fine MJ. Dual use of Department of Veterans Affairs and medicare benefits and use of test strips in veterans with type 2 diabetes mellitus. JAMA Intern Med. 2015 Jan;175(1):26-34.
  • Zullig LL, Gellad WF, Moaddeb J, Crowley MJ, Shrank W, Granger BB, Granger CB, Trygstad T, Liu LZ, Bosworth HB. Improving diabetes medication adherence: successful, scalable interventions. Patient Prefer Adherence. 2015 Jan 23;9:139-49.
  • Hanlon JT, Aspinall SL, Handler SM, Gellad WF, Stone RA, Semla TP, Pugh MJ, Dysken MW. Potentially suboptimal prescribing for older veteran nursing home patients with dementia. Ann Pharmacother. 2015 Jan;49(1):20-8.
  • Lo-Ciganic WH, Perera S, Gray SL, Boudreau RM, Zgibor JC, Strotmeyer ES, Donohue JM, Bunker CH, Newman AB, Simonsick EM, Bauer DC, Satterfield S, Caserotti P, Harris T, Shorr RI, Hanlon JT; Health, Aging and Body Composition Study. Statin use and decline in gait speed in community-dwelling older adults. J Am Geriatr Soc. 2015 Jan;63(1):124-9. doi: 10.1111/jgs.13134.

2014

  • Prentice JC, Conlin PR, Gellad WF, Edelman D, Lee TA, Pizer SD. Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes. Value Health. 2014 Dec;17(8):854-62.
  • Gellad WF, Stein BD, Ruder T, Henderson R, Frazee SG, Mehrotra A, Donohue JM. Geographic variation in receipt of psychotherapy in children receiving attention-deficit/hyperactivity disorder medications. JAMA Pediatr. 2014 Nov;168(11):1074-6.
  • Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Booth MJ, Motala A, Shekelle PG. Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Intern Med. 2014 Nov;161(10):711-23. 
  • Donohue JM. The impact and evolution of Medicare Part D. N Engl J Med. 2014 Aug 21;371(8):693-5. 
  • Anderson TS, Good CB, Gellad WF. Potential conflicts of interest for academic medical center leaders--reply. JAMA. 2014 Aug 6;312(5):558-9. 
  • Tang Y, Gellad WF, Men A, Donohue JM. Impact of medicare part D plan features on use of generic drugs. Med Care. 2014 Jun;52(6):541-8.
  • Anderson TS, Dave S, Good CB, Gellad WF. Academic medical center leadership on pharmaceutical company boards of directors. JAMA. 2014 Apr 2;311(13):1353-5.
  • Gellad WF, Choi P, Mizah M, Good CB, Kesselheim AS. Assessing the chiral switch: approval and use of single-enantiomer drugs, 2001 to 2011. Am J Manag Care. 2014 Mar 1;20(3):e90-7.
  • Donohue J, O'Malley AJ, Horvitz-Lennon M, Taub AL, Berndt ER, Huskamp HA. Changes in physician antipsychotic prescribing preferences, 2002-2007. Psychiatr Serv. 2014 Mar 1;65(3):315-22. PMID: 24337224.
  • Marcum ZA, Driessen J, Thorpe CT, Gellad WF, Donohue JM. Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with Medicare Part D. J Am Geriatr Soc. 2014 Feb;62(2):244-52.
  • Gellad WF. Targeted cancer therapy: from bench to bedside to patient. J Clin Oncol. 2014 Feb 1;32(4):268-70.
  • James AE 3rd, Gellad WF, Primack BA. Implications of new insurance coverage for access to care, cost-sharing, and reimbursement. JAMA. 2014 Jan 15;311(3):241-2.

2013

  • Hanlon JT, Boudreau RM, Perera S, Strotmeyer ES, Newman AB, Simonsick EM, Shorr RI, Bauer DC, Donohue JM. Racial differences in antilipemic use and lipid control in high-risk older adults: post-Medicare Part D. Am Heart J. 2013 Oct;166(4):792-7. 
  • Borrero S, Zhao X, Mor MK, Schwarz EB, Good CB, Gellad WF. Adherence to hormonal contraception among women veterans: differences by race/ethnicity and contraceptive supply. Am J Obstet Gynecol. 2013 Aug;209(2):103.e1-11.  
  • Gellad WF, Donohue JM, Zhao X, Mor MK, Thorpe CT, Smith J, Good CB, Fine MJ, Morden NE. Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison. Ann Intern Med. 2013 Jul;159(2):105-14.
  • Gallini A, Donohue JM, Huskamp HA. Diffusion of antipsychotics in the US And French markets, 1998-2008. Psychiatr Serv. 2013 Jul;64(7):680-7.
  • Gellad WF, Yealy D, Fine M. Computers and the diagnosis of pneumonia. JAMA Intern Med. 2013 Apr;173(8):701-2.
  • Huskamp HA, O'Malley AJ, Horvitz-Lennon M, Taub AL, Berndt ER, Donohue JM. How quickly do physicians adopt new drugs? The case of second-generation antipsychotics. Psychiatr Serv. 2013 Apr 1;64(4):324-30.

2012

  • Gellad WF, Aspinall SL, Handler SM, Stone RA, Castle N, Semla TP, Good CB, Fine MJ, Dysken M, Hanlon JT. Use of antipsychotics among older residents in VA nursing homes. Med Care. 2012 Nov;50(11):954-60.
  • Gellad W, Mor M, Zhao X, Donohue J, Good C. Variation in use of high-cost diabetes mellitus medications in the VA healthcare system. Arch Intern Med. 2012 Nov;172(20):1608-9.  
  • Zhang Y, Gellad WF, Zhou L, Lin YJ, Lave JR. Access to and use of $4 generic programs in Medicare. J Gen Intern Med. 2012 Oct;27(10):1251-7.
  • Primack BA, Hopkins M, Hallett C, Carroll MV, Zeller M, Dachille K, Kim KH, Fine MJ, Donohue JM. US health policy related to hookah tobacco smoking. Am J Public Health. 2012 Sep;102(9):e47-51.
  • Donohue JM, Marcum ZA, Gellad WF, Lave JR, Men A, Hanlon JT. Medicare Part D and potentially inappropriate medication use in the elderly. Am J Manag Care. 2012 Sep;18(9):e315-22.
  • Thorpe JM, Thorpe CT, Kennelty KA, Gellad WF, Schulz R. The impact of family caregivers on potentially inappropriate medication use in noninstitutionalized older adults with dementia. Am J Geriatr Pharmacother. 2012 Aug;10(4):230-41.
  • Gellad WF, Good CB, Amuan ME, Marcum ZA, Hanlon JT, Pugh MJ. Facility-level variation in potentially inappropriate prescribing for older veterans. J Am Geriatr Soc. 2012 Jul;60(7):1222-9.  
  • Marcum ZA, Gellad WF. Medication adherence to multidrug regimens. Clin Geriatr Med. 2012 May;28(2):287-300.  
  • Gellad WF, Donohue JM, Zhao X, Zhang Y, Banthin JS. The financial burden from prescription drugs has declined recently for the nonelderly, although it is still high for many. Health Aff (Millwood). 2012 Feb;31(2):408-16.
  • Donohue JM, Morden NE, Gellad WF, Bynum JP, Zhou W, Hanlon JT, Skinner J. Sources of regional variation in Medicare Part D drug spending. N Engl J Med. 2012 Feb;366(6):530-8.
  • Thorpe CT, Lassila HC, O'Neil CK, Thorpe JM, Hanlon JT, Maher RL Jr. Reconsideration of key articles regarding medication-related problems in older adults from 2011. Am J Geriatr Pharmacother. 2012 Feb;10(1):2-13.